SBI Pharma Div 100644

| INF200K01461

NAV

$ 53.54

NAV Day Change

-0.58 | -1.08

As of 21/05/2013 09:30:00 | INR

TTM Yield

0.00%

Load

Multiple

Total Assets

Turnover

43.5%

Status

Open

Min. Inv.

2,000

30-Day SEC Yield

Growth of 10,000

03/31/2007 – 03/08/2012

Zoom: 1M 3M YTD 1Y 3Y 5Y 10Y Maximum

This fund's investment structure and legal structure substantially changed as of . Either investment strategy or different legal structure significantly changed on the date. Prior to that, the fund followed a significantly different investment strategy, and it operated under a different legal structure.

Performance

	YTD	1 Mo	1 Yr	3 Yr	5 Yr	10 Yr

Growth of 10,000	10,792	10,420	13,315	16,747	19,392	94,897
Fund	7.92	4.20	33.15	18.75	14.16	25.23
+/- S&P BSE Healthcare PR	-1.80	-1.43	-1.30	-0.37	-1.85	3.47
+/- Category	2.81	-0.37	5.48	4.09	-4.49	2.31
% Rank in Cat	1	100	1	1	83	1
# of Funds in Cat	7	14	7	7	7	4
* Annualized returns. Data as of 05/21/2013. Currency is displayed in INR.

Top Holdings

		Weight %	Last Price	Day Chg %	52-Week Range

	Sun Pharmaceuticals Industries Ltd.	20.87	1001.90INR	2.87	606.00 - 1013.70
	Dr. Reddy Laboratories, Ltd.	14.06	2055.75INR	1.73	1590.25 - 2152.00
	Cipla Ltd.	11.88	415.70INR	-0.56	305.75 - 435.00
	Glenmark Pharmaceuticals Ltd.	7.41	564.65INR	-1.57	355.05 - 609.00
	Divi's Laboratories Ltd.	7.20	995.00INR	-1.14	924.45 - 1234.40
	% Assets in Top 5 Holdings	61.42
Increase Decrease New to Portfolio Portfolio Date :04/30/2013, Price data delayed 15 ~ 30 minutes

Top Sectors

Fund

3 Yr High

3 Yr Low

Cat Avg

Fund

Cat Avg

Healthcare

100.00

97.07

Basic Materials

0.00

Consumer Cyclical

0.00

Financial Services

0.00

RealEstate

0.00

Portfolio Date: 04/30/2013

Dividend and Capital Gains Distributions

Distribution Date	Distribution NAV	Long-Term Capital Gain	Short-Term Capital Gain	Dividend Income	Distribution Total	Return of Capital

03 Jan 2005	--	0.0000	0.0000	3.9000	3.9000	0.0000
06 Sep 2004	--	0.0000	0.0000	3.0000	3.0000	0.0000
22 Sep 2003	--	0.0000	0.0000	1.2000	1.2000	0.0000

Currency: INR

Asset Allocation

Type	% Net	% Short	% Long
Cash	7.07	0.27	7.35
US Stocks	0.00	0.00	0.00
Non US Stocks	92.93	0.00	92.93
Bonds	0.00	0.00	0.00
Other	0.00	0.00	0.00
Note: Contains derivatives or short positions
As of 04/30/2013

Management

	Start Date

Tanmaya Desai	06/01/2011

Style Map

Weighted Average of holdings

75% of fund's stock holdings

SBI Pharma Div 100644

NAV

NAV Day Change

TTM Yield

Load

Total Mkt Val

Total Assets

Expenses

Fee Level

Turnover

Status

Min. Inv.

30-Day SEC Yield

Category

Growth of 10,000

Performance

Top Holdings

Top Sectors

Dividend and Capital Gains Distributions

Asset Allocation

Management

Style Map